Medicenna Therapeutics Statistics
Total Valuation
MDNAF has a market cap or net worth of 53.33 million. The enterprise value is 32.58 million.
| Market Cap | 53.33M |
| Enterprise Value | 32.58M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +7.07% |
| Shares Change (QoQ) | +1.52% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 50.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 4.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.74 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.86 |
Financial Position
The company has a current ratio of 10.09, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.09 |
| Quick Ratio | 9.90 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -149.09% and return on invested capital (ROIC) is -64.43%.
| Return on Equity (ROE) | -149.09% |
| Return on Assets (ROA) | -42.08% |
| Return on Invested Capital (ROIC) | -64.43% |
| Return on Capital Employed (ROCE) | -64.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.17M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.37% in the last 52 weeks. The beta is 1.08, so MDNAF's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -50.37% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 1.28 |
| Relative Strength Index (RSI) | 37.02 |
| Average Volume (20 Days) | 53,114 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.99M |
| Pretax Income | -18.69M |
| Net Income | -18.69M |
| EBITDA | -12.98M |
| EBIT | -12.99M |
| Earnings Per Share (EPS) | -0.25 |
Balance Sheet
The company has 20.85 million in cash and 120,931 in debt, giving a net cash position of 20.73 million.
| Cash & Cash Equivalents | 20.85M |
| Total Debt | 120,931 |
| Net Cash | 20.73M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.13M |
| Book Value Per Share | 0.16 |
| Working Capital | 20.04M |
Cash Flow
In the last 12 months, operating cash flow was -11.36 million and capital expenditures -22,935, giving a free cash flow of -11.38 million.
| Operating Cash Flow | -11.36M |
| Capital Expenditures | -22,935 |
| Free Cash Flow | -11.38M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MDNAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.07% |
| Shareholder Yield | -7.07% |
| Earnings Yield | -35.05% |
| FCF Yield | -21.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |